Compare Natera Inc. Common Stock (NTRA) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Waste Management, Inc. — how do they compare? Natera Inc. Common Stock trades at $392.78 (market cap $57.03B), while Waste Management, Inc. trades at $219.02 (market cap $86.24B). The key difference: Waste Management, Inc. is the larger of the two by market cap, and Waste Management, Inc. pays a 1.75% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Waste Management, Inc. for 131 Days on average.
| NTRA | WM | |
|---|---|---|
Market Cap | $57.03B | $86.24B |
Volume | 1,131,157 | 1,938,815 |
Sector | Health | Industrials |
52-Week High | $425.64 | $246.51 |
52-Week Low | $179.42 | $196.77 |
Typical Hold Time | 0 Days | 131 Days |
Enterprise Value | $56.18B | $109.04B |
Dividend Yield | — | 1.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Waste Management (WM) trades at $211.83, up 0.33% with a bullish technical signal despite mixed moving averages. The company demonstrates strong fundamentals with $25.2B revenue, 11.12% net margin, and robust cash flow generation. Recent earnings show two beats out of three quarters, with Q3 2026 results pending. Analyst consensus is strongly positive with 54% buy ratings and no sell recommendations.
WM presents a compelling investment case with consistent revenue growth, strong profitability metrics, and defensive business model. However, elevated valuation multiples (P/E 29.96) and rising debt levels warrant caution. The stock offers stability through economic cycles but faces margin pressure from cost inflation and competitive threats in waste management services.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
